Loading...
Loading...
Among the 1 tracked institutional investors we monitor, GTBP (GT BIOPHARMA INC) is held with a combined value of $4.07K across 8,312 shares. The largest holder is BlackRock, Inc. with a position worth $4.07K. 1 fund reduced its position.
Total Institutional Value
$4.07K
Total Shares Held
8,312
Institutional Holders
1
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $4.07K | 0.00% | -1.1% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of GTBP with a position worth $4.07K, representing 0.00% of their portfolio. In total, 1 institutional investors hold GTBP with a combined value of $4.07K.
Institutional investors hold $4.07K worth of GTBP stock across 1 positions. The largest institutional holder is BlackRock, Inc. with $4.07K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For GTBP, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their GTBP positions.
Last Close
$0.29
2026-08-21
YTD
-64.7%
1% of 52-week range